chr20-43702560-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000217026.5(MYBL2):āc.1022A>Gā(p.Asn341Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00143 in 1,614,202 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
ENST00000217026.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYBL2 | NM_002466.4 | c.1022A>G | p.Asn341Ser | missense_variant | 8/14 | ENST00000217026.5 | NP_002457.1 | |
MYBL2 | NM_001278610.2 | c.950A>G | p.Asn317Ser | missense_variant | 7/13 | NP_001265539.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYBL2 | ENST00000217026.5 | c.1022A>G | p.Asn341Ser | missense_variant | 8/14 | 1 | NM_002466.4 | ENSP00000217026.4 | ||
MYBL2 | ENST00000396863.8 | c.950A>G | p.Asn317Ser | missense_variant | 7/13 | 2 | ENSP00000380072.4 |
Frequencies
GnomAD3 genomes AF: 0.00754 AC: 1148AN: 152212Hom.: 14 Cov.: 32
GnomAD3 exomes AF: 0.00214 AC: 538AN: 251440Hom.: 7 AF XY: 0.00157 AC XY: 214AN XY: 135890
GnomAD4 exome AF: 0.000792 AC: 1158AN: 1461872Hom.: 13 Cov.: 31 AF XY: 0.000689 AC XY: 501AN XY: 727232
GnomAD4 genome AF: 0.00755 AC: 1150AN: 152330Hom.: 14 Cov.: 32 AF XY: 0.00686 AC XY: 511AN XY: 74494
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 31, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at